Leiomyosarcoma Clinical Trials in Santa Monica, California

4 studies are recruiting for leiomyosarcoma in Santa Monica, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Metastatic Leiomyosarcoma Biomarker Protocol

    Leiomyosarcoma (LMS) is one of the most prevalent soft tissue sarcomas (STS) and can occur in various sites including soft tissue, uterus and retroperitoneal large vessels. Metastatic disease occurs in approximately 50% of patients diagnosed with leiomyosarcoma and prognosis is poor in setting of m…

    Stage
    Not phased
    Ages
    Any age
    Site
    Sarcoma Oncology Research Center, Santa Monica, California
    Locations
    11 in total
    Run by
    University of Michigan Rogel Cancer Center

    See if you can join NCT05653388 on ClinicalTrials.gov

  2. A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors

    The purpose of this study is to investigate the study drug, OKN4395, administered alone and in combination with pembrolizumab. The overall objectives of this study are to determine the safety and tolerability (degree to which side effects of a drug can be tolerated) of OKN4395 alone and in combinat…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Sarcoma Oncology Center, Santa Monica, California
    Locations
    10 in total
    Run by
    Epkin

    See if you can join NCT06789172 on ClinicalTrials.gov

  3. Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)

    THIS STUDY IS CURRENTLY RECRUITING PATIENTS WITH ALVEOLAR SOFT PART SARCOMA ONLY AND IS NO LONGER RECRUITING PATIENTS WITH SYNOVIAL SARCOMA OR LEIOMYOSARCOMA. This study evaluates the safety and efficacy of AL3818 (anlotinib) hydrochloride in the treatment of metastatic or advanced alveolar soft pa…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Sarcoma Oncology Center, Santa Monica, California
    Locations
    24 in total
    Run by
    Advenchen Laboratories, LLC

    See if you can join NCT03016819 on ClinicalTrials.gov

  4. Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Soft Tissue Sarcoma

    This is an open label phase 2 study using metronomic doses of trabectedin, gemcitabine and dacarbazine given intravenously.

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Sant P Chawla, Santa Monica, California
    Run by
    Sarcoma Oncology Research Center, LLC

    See if you can join NCT04535271 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.